N -Alkyl-octahydroisoquinolin-1-one-8-carboxamides: Selective and nonbasic ?-opioid receptor ligands

ACS Medicinal Chemistry Letters

Volumn 1, Issue 5, 2010, Pages 189-193

  Frankowski, Kevin J ^a   Ghosh, Partha ^a   Setola, Vincent ^b   Tran, Thuy B ^b   Roth, Bryan L ^b   Aubé, Jeffrey ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYL GROUP; AMIDE; DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; ISOQUINOLINE DERIVATIVE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OCTAHYDROISOQUINOLIN 1 ONE 8 CARBOXAMIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; MOLECULAR PROBE; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 77956162799     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml100040t     Document Type: Article

References (22)

1. McCurdy, C. R.; Prisinzano, T. E. Opioid receptor ligands. In Burger's Medicinal Chemistry, Drug Discovery and Development, 7 th ed.; Abraham, D. J., Rotella, D. P., Eds.; John Wiley & Sons: New York, NY, 2010.
2. Aldrich, J. V.; McLaughlin, J. P. Peptide kappa opioid receptor ligands: Potential for drug development AAPS J. 2009, 11, 312-322
3. Metcalf, M. D.; Coop, A. Kappa opioid antagonists: Past successes and future prospects AAPS J. 2005, 7, E704-E722
4. Prisinzano, T. E.; Tidgewell, K.; Harding, W. W. k Opioids as potential treatments for stimulant dependance AAPS J. 2005, 7, E592-E599
5. Glick, S. D.; Maisonneuve, I. M.; Raucci, J.; Archer, S. Kappa-opioid inhibition of morphine and cocaine self-administration Brain Res. 1995, 681, 147-152
6. Reindl, J. D.; Rowan, K.; Carey, A. N.; Peng, X.; Neumeyer, J. L.; McLaughlin, J. P. Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test Pharamcology 2008, 81, 229-235
7. Knoll, A. T.; Meloni, E. G.; Thomas, J. B.; Carroll, F. I.; Carlezon, W. A., Jr. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats J. Pharmacol. Exp. Ther. 2007, 323, 838-845
8. Mague, S. D.; Pliakas, A. M.; Todtenkopf, M. S.; Thomasiewicz, H. C.; Zhang, Y.; Stevens, W. C. J.; Jones, R. M.; Portoghese, P. S.; Carlezon, W. A., Jr. Antidepressant-like effects of ?-opioid receptor antagonists in the forced swim test in rats J. Pharmacol. Exp. Ther. 2003, 305, 323-330
9. Millan, M. J. Kappa-opioid receptor-mediated antinociception in the rat. 1. Comparative actions of mu -opioids and kappa -opioids against noxious thermal, pressure and electrical stimuli J. Pharmacol. Exp. Ther. 1989, 251, 334-341
10. Roth, B. L.; Baner, K.; Westkaemper, R.; Siebert, D.; Rice, K. C.; Steinberg, S.; Ernsberger, P.; Rothman, R. B. Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective sgonist Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 11934-11939
11. Kaczor, A.; Matosiuk, D. Non-peptide opioid receptor ligands - Recent advances. Part I. Agonists Curr. Med. Chem. 2002, 9, 1567-1589
12. Kaczor, A.; Matosiuk, D. Non-peptide opioid receptor ligands - Recent advances. Part II. Antagonists Curr. Med. Chem. 2002, 9, 1591-1603
13. For a recently reported KOR agonist, see Kracht, D.; Rack, E.; Schepmann, D.; Fröhlich, R.; Wünsch, B. Stereoselective synthesis and structure?affinity relationships of bicyclic receptor agonists Org. Biomol. Chem. 2010, 8, 212-225
14. VonVoigtlander, P. F.; Szmuszkovicz, J. Benzeneacetamide amines: Structurally novel non-? opioids J. Med. Chem. 1982, 25, 1125-1126
15. Jones, R. M.; Portoghese, P. S. 5?-Guanidinonaltrindole, a highly selective and potent ?-opioid receptor antagonist Eur. J. Pharmacol. 2000, 396, 49-52
16. Cueva, J. P.; Cai, T. B.; Mascarella, S. W.; Thomas, J. B.; Navarro, H. A.; Carroll, F. I. Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3 R)-7-hydroxy- N -[(1 S)-1-{[(3 R,4 R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3, 4-tetrahydro-3-isoquinolinecarboxamide (JDTic) J. Med. Chem. 2009, 52, 7463-7472
17. Cai, T. B.; Zou, Z.; Thomas, J. B.; Brieaddy, L.; Navarro, H. A.; Carroll, F. I. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa receptor antagonist (3 R)-7-hydroxy- N -((1 S)-1-{[(3 R,4 R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2- methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) J. Med. Chem. 2008, 51, 1849-1860
18. Frankowski, K. J.; Hirt, E. E.; Zeng, Y.; Neuenswander, B.; Fowler, D.; Schoenen, F.; Aubé, J. Synthesis of N -alkyl-octahydroisoquinolin-1-one- 8-carboxamide libraries using a tandem Diels?Alder/acylation sequence J. Comb. Chem. 2007, 9, 1188-1192
19. Plietker, B.; Seng, D.; Fröhlich, R.; Metz, P. High pressure intramolecular Diels?Alder reactions of vinylsulfonates and vinylsulfonamides Tetrahedron 2000, 56, 873-879
20. For a more detailed discussion of these possible pathways, see ref 18.
21. Data were measured as the mean % inhibition (N = 4 determinations) for compounds tested at receptor subtypes. Significant inhibition is considered >50%. For full experimental details, see the Supporting Information.
22. Launay, J.-M.; Hervé, P.; Peoc'h, K.; Tournois, C; Callebert, J; Neigil, C. G.; Etienne, N.; Drouet, L.; Humbert, M.; Simonneau, G.; Maroteaux., L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension Nature Med. 2002, 8, 1129-1135